Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) Subsidiary Files Amendment Revising Acquisition Value to KRW 870.5B for Singapore’s Dyna-Mac

Posted on October 14, 2024July 21, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) Subsidiary Files Amendment Revising Acquisition Value to KRW 870.5B for Singapore’s Dyna-Mac

Source Facts: Financial Supervisory Service DART / 2024-10-14

Disclosure Type: Decision on Acquisition of Shares and Equity Securities of Other Corporations by Major Subsidiary (Amendment)

💡 3-Second Summary

Hanwha Aerospace’s Singapore subsidiary (Hanwha Ocean SG Holdings) has filed an amendment updating the total acquisition value for its planned 100% stake acquisition in Dyna-Mac Holdings Ltd. to approx. KRW 870.5B (revised from approx. KRW 779.7B).

📊 1. Key Disclosure Details & Major Figures

  • Target Company: Dyna-Mac Holdings Ltd. (Nationality: Singapore / CEO: LIM AH CHENG / Business: Offshore structure manufacturing)
  • Total Outstanding Shares: 1,179,985,415 shares (revised from 1,115,364,667 shares)
  • Acquisition Details:
    • Number of Shares: 1,260,729,835 common shares (final acquisition volume including warrants / revised from 1,260,967,835 shares)
    • Acquisition Amount: KRW 870,460,451,085 (approx. KRW 870.46B / revised from KRW 779,663,978,187)
  • Post-Acquisition Holdings & Ownership: 1,260,729,835 shares / 100.0% ownership stake
  • Method & Purpose: Tender offer / Securing future growth drivers and creating strategic synergies
  • Scheduled Completion Date: December 02, 2024 (expected final tender offer closing date)
  • Subsidiary Name: Hanwha Ocean SG Holdings Pte. Ltd. (CEO: Yong In Shin / Business: Investments)

📈 2. Expert Perspective: What This Disclosure Means for Investors

This disclosure reports an amendment regarding the acquisition parameters for Singapore-listed offshore structure builder Dyna-Mac Holdings Ltd., conducted by Hanwha Aerospace’s Singapore subsidiary, Hanwha Ocean SG Holdings Pte. Ltd.

Reflecting updates to the target company’s total outstanding shares and recalculated share counts including warrants, the total acquisition value was revised from KRW 779.7B to KRW 870.5B. The scheduled target date of December 2, 2024, corresponds to the expected final tender offer closing date, which remains subject to tender progress and antitrust approvals in Singapore. Market participants can track subsequent disclosures to confirm execution progress leading up to the December 2 schedule window.

📝 Editor’s Comment (by K-STOCK Editor)

Hanwha Aerospace’s subsidiary has updated its regulatory filing for the acquisition of Singapore’s Dyna-Mac, adjusting the reported total transaction value to approximately KRW 870.5B.

From an analytical standpoint, the amendment reflects updated share metrics and recalculated consideration figures as disclosed. Key observation points include monitoring Singapore regulatory approval timelines and tracking whether any further schedule adjustments occur ahead of the December 2 target date.

📢 Disclaimer & Source Notice

Source: This content was structured and newly compiled based on official data submitted to the Financial Supervisory Service’s DART system.

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] ISU PETASYS (007660) to Acquire 85% Stake in Thai Joint Venture ‘ISU-APEX’ for Overseas Market Expansion
Next Post: [Disclosure] Celltrion 068270, Submits Phase 3 Clinical Trial Application for Cosentyx Biosimilar CT-P55 in Europe (Part 1&2)

Related Posts

[Disclosure] SK square (402340) Schedules AGM for March 27: Files Official Report on Overlapping Shareholder Meeting Date Semiconductors
[Disclosure] Hanwha Ocean (042660) Amends Contract Expiration Date for KRW 828.3B Order of 1 Fixed Platform for Middle East Shipowner Disclosures
[Disclosure] Hanwha Aerospace (012450) Reports Subsidiary ‘HAA No.1 PTY LTD’ Decides on KRW 266.9B Rights Offering… Change in Largest Shareholder Expected Post-Issuance Disclosures
[Disclosure] Hanwha Ocean (042660) Decides on KRW 139.7B Debt Guarantee for U.S. Affiliate Hanwha Philly Shipyard Inc. Disclosures
[Disclosure] Hanwha Aerospace (012450) Files Amendment Shortening Intercompany Loan Maturity to November 26, 2024 Disclosures
[Disclosure] Celltrion (068270) Posts Consolidated Revenue of KRW 4.16T and Operating Profit of KRW 1.17T for the Fiscal Year; Receives ‘Unqualified’ Auditor’s Opinion Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme